Genzyme, a Sanofi company, has obtained an approval from Health Canada for its Lemtrada (alemtuzumab) for the treatment of relapsing remitting multiple sclerosis (RRMS). Health Canada has approved Lemtrada for the management of adult ...
BIND Therapeutics, a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins, has amended its development and commercialization collaboration agreement with Amgen to extend the period ...
PURE Bioscience, Inc., creator of the patented silver dihydrogen citrate (SDC) antimicrobial, has entered into a five-year strategic collaboration agreement with St. Louis-based Intercon Chemical Company (ICC). The agreement consists of a ...
Tags: PURE Bioscience, Chemical Company
Monsanto Company and Novozymes today announce a long-term strategic alliance to transform research and commercialization of sustainable microbial products that will provide a new platform of solutions for growers around the world. The ...
Tags: Monsanto, Novozymes, sustainable, microbial products, BioAg
Roche and Prothena have agreed to jointly develop and commercialize new antibodies that target alpha-synuclein, including PRX002, Prothena's monoclonal antibody for the treatment of Parkinson's disease (PD). Currently, PRX002 is in ...
US-based Agios Pharmaceuticals has announced an extension of one additional year to the period of exclusivity for their strategic cancer metabolism collaboration with Celgene. Celgene research president Dr Thomas Daniel noted the quality ...
Johnson & Johnson Innovation and its affiliate Janssen have entered into new collaborations with two Canadian early-stage drug technology development centers, NEOMED and MaRS Innovation, to discover and develop new bio/pharmaceutical ...
Sapphire Energy, Inc., one of the world leaders in algae-based Green Crude oil production, and Phillips 66 (NYSE: PSX), an integrated energy manufacturing and logistics company, announced a strategic joint development agreement aimed at ...
Tags: Metallurgy, Mineral, Energy, Crude Oil, Oil
Echo Therapeutics, a medical device company developing its Symphony CGM system as a non-invasive, wireless continuous glucose monitoring system, has entered into a strategic collaboration agreement with Medical Technologies Innovation Asia ...
US-based life sciences venture capital firm Versant Ventures is expanding its operations into Canada in order to invest in early-stage drug discovery programs. The company has established an office in Vancouver this year and created a new ...
Tags: Versant Ventures, Drug Discovery
Proteostasis Therapeutics and Biogen Idec have collaborated to research and develop new therapies based on the inhibition of Usp14, a deubiquitinating enzyme, for the treatment of certain neurodegenerative disorders. Under the deal, ...
Automotive companies with well-defined innovation strategies have competitive advantages ranging from talent attraction to revenue growth, according to a recent PwC study. The highway to growth: strategies for automotive innovation released ...
Asahi Kasei Zoll Medical, the Japanese subsidiary of Zoll Medical, has obtained Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for its X Series monitor/defibrillator, designed primarily for emergency medical ...
Foundation Medicine, a molecular information company, has announced the launch of its second clinical product, FoundationOne Heme, a fully informative genomic profile for hematologic cancers (leukemia, lymphoma and myeloma), as well as many ...
Auxilium Pharmaceuticals, a biopharmaceutical company, has obtained an approval from the US Food and Drug Administration (FDA) for Xiaflex (collagenase clostridium histolyticum) for the treatment of Peyronie's disease. The company claims ...
Tags: Peyronie's Disease Drug, Medicine